Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial

BACKGROUND: BI 695501 is an FDA-approved biosimilar to adalimumab reference product (RP). VOLTAIRE-X was a randomized clinical trial to assess outcomes with a biosimilar monoclonal antibody in line with the FDA requirements for designation as an ‘interchangeable’ biosimilar. OBJECTIVE: The aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Menter, Alan, Cohen, Stanley, Kay, Jonathan, Strand, Vibeke, Gottlieb, Alice, Hanauer, Stephen, Eduru, Sravan Kumar, Buschke, Susanne, Lang, Benjamin, Liesenfeld, Karl-Heinz, Schaible, Jennifer, McCabe, Dorothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464749/
https://www.ncbi.nlm.nih.gov/pubmed/35934770
http://dx.doi.org/10.1007/s40257-022-00708-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464749/
https://www.ncbi.nlm.nih.gov/pubmed/35934770
http://dx.doi.org/10.1007/s40257-022-00708-w

Ejemplares similares